Healthcare -
Medical - Devices - NASDAQ - US
$ 8.65
1.29 %
$ 227 M
Market Cap
-3.88
P/E
Price Target
Average
4.05%
Revenue Forecast
Estimate
131.59%
EBIT
Estimate
--146.39%
Net Income
Estimate
134.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AVITA Medical, Inc.
Wall Street analysts predict an average 1-year price target for RCEL of $9 , with forecasts ranging from
a
low of
$9 to a high of $9 .
RCEL Lowest Price Target
Wall Street Target
9 USD
4.05%
RCEL Average Price Target
Wall Street Target
9 USD
4.05%
RCEL Highest Price Target
Wall Street Target
9 USD
4.05%
REVENUE FORECAST
Revenue Forecast Chart RCEL
EBIT FORECAST
EBIT Forecast Chart RCEL
NET INCOME FORECAST
Net Income Chart RCEL